By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Ra Pharma  

One Kendall Square
Building 1400 West, 3rd Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-401-4060 Fax: 617-401-4061


Key Statistics

Ownership: Public

Web Site: Ra Pharma
Symbol: RARX

Company News
Ra Pharma (RARX) Presents Data On Oral Small Molecule Complement Inhibitors At The 22nd Congress Of European Hematology Association 6/26/2017 6:45:43 AM
Ra Pharma (RARX) To Host Conference Call On Initial Phase II Data For RA101495 In PNH 6/22/2017 7:17:29 AM
Ra Pharma (RARX) Reports First Quarter 2017 Financial Results And Provides Corporate Update 5/12/2017 6:30:25 AM
Ra Pharma (RARX) Initiates Dosing Of RA101495 In PNH Patients 4/26/2017 6:13:24 AM
Ra Pharma (RARX) Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/7/2017 6:32:34 AM
Ra Pharma (RARX) Supports 10th Annual Rare Disease Day And Joins Global Movement To Raise Awareness For Rare Diseases 2/28/2017 7:26:31 AM
Ra Pharma (RARX) Reports Third Quarter 2016 Financial Results And Provides Corporate Update 11/30/2016 11:08:50 AM
Ra Pharma (RARX) Receives Orphan Drug Designation In The European Union For RA101495 For Treatment Of Paroxysmal Nocturnal Hemoglobinuria 11/17/2016 11:30:53 AM
Ra Pharma (RARX)'s $92 Million Debut is the Ninth Massachusetts Biotech IPO of 2016 10/27/2016 6:29:55 AM
Ra Pharma Announces Pricing Of Initial Public Offering 10/26/2016 10:16:02 AM